Shanghai Best-Link Bioscience LLC
- Biotech or pharma, therapeutic R&D
Best-Link Bio is revolutionizing drug delivery with its innovative TME-targeting nano-conjugate system (NMPDC). This cutting-edge approach overcomes tumor microenvironment delivery barriers through optimized nanoscale design, enhancing drug penetration and stability. Our nano-conjugates selectively target highly expressed enzymes, facilitating the release of potent small molecule payloads directly within tumors. Leveraging the bystander effect, these payloads diffuse into tumor cells, bypassing traditional targeting challenges with deep tissue penetration. Our platform is versatile, offering pan-tumor treatment potential, with preclinical results demonstrating remarkable efficacy against a wide range of cancers, including pancreatic, lung, colorectal, triple-negative breast cancer and malignant thymoma. Multiple pipelines of the NMPDC platform have entered the clinical stage.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}